Table 1.
Demographic characteristics of patients.
| Total | MH | |||||
|---|---|---|---|---|---|---|
| TD | PIGD | p | TD | PIGD | p | |
| Number | 90 | 98 | 22 | 38 | ||
| Age (years) | 66.41 ± 8.48 | 67.43 ± 10.01 | 0.456 | 66.45 ± 8.13 | 68.39 ± 9.91 | 0.440 |
| Male (%) | 50 (55.6%) | 45 (45.9%) | 0.187 | 14 (63.6%) | 19 (50%) | 0.306 |
| BMI | 23.63 ± 3.43 | 23.62 ± 3.35 | 0.981 | 23.44 ± 3.01 | 22.66 ± 3.15 | 0.505 |
| Education (%) | 0.265 | 0.133 | ||||
| Illiteracy | 12 (13.3%) | 13 (13.3%) | 2 (9.1%) | 4 (10.5%) | ||
| Primary school | 18 (20.0%) | 10 (10.2%) | 7 (31.8%) | 3 (7.9%) | ||
| Middle school | 45 (50.0%) | 53 (54.1%) | 10 (45.5%) | 24 (63.2%) | ||
| College or above | 15 (16.7%) | 22 (22.4%) | 3 (13.6%) | 7 (18.4%) | ||
| H-Y stage | 2.20 ± 0.66 | 2.59 ± 0.57 | <0.001 | 2.50 ± 0.56 | 2.51 ± 0.62 | 0.722 |
| Disease duration(years) | 5.58 ± 4.22 | 5.70 ± 4.19 | 0.782 | 7.40 ± 4.06 | 5.84 ± 4.26 | 0.106 |
| UPDRSIII | 31.06 ± 16.13 | 30.47 ± 12.89 | 0.945 | 35.55 ± 17.97 | 27.84 ± 11.65 | 0.125 |
| LEDD (mg) | 383.55 ± 377.74 | 546.94 ± 392.55 | 0.002 | 446.69 ± 264.99 | 561.98 ± 345.64 | 0.182 |
| MH(%) | 22 (24.4%) | 38 (38.8%) | 0.035 | / | / | |
Data are presented as the mean ± SD, n (%). Bold value is statistically significant (p < 0.05). MH, minor hallucination; TD, tremor dominant; PIGD, postural instability and gait difficulty; BMI, body mass index; H-Y, Hoehn and Yahr; UPDRS III, Unified Parkinson’s Disease Rating Scale part 3; LEDD, Levodopa equivalent daily dose.